Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 225

    1.

    [Place of fibrates for the treatment of patients with atherogenic dyslipidemia]

    Ducobu J, Scheen AJ, Legat P, De Backer G, Van Gaal L, Velkeniers B, Kartounian J, Maes M, Hermans M.

    Rev Med Liege. 2009 Oct;64(10):512-8. French. PMID: 19911665 [PubMed - in process]Related articles

    2.

    [Improved glucose control and weight loss with exenatide in patients with type 2 diabetes: results of a retrospective observational multicentre Belgian study]

    De Block C, Paquot N, Daoudi N, Ballaux D, Van Gaal LF, Scheen AJ.

    Rev Med Liege. 2009 Oct;64(10):488-95. French. PMID: 19911661 [PubMed - in process]Related articles

    3.

    Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study.

    Astrup A, Rössner S, Van Gaal L, Rissanen A, Niskanen L, Al Hakim M, Madsen J, Rasmussen MF, Lean ME; NN8022-1807 Study Group.

    Lancet. 2009 Nov 7;374(9701):1606-16. Epub 2009 Oct 23.PMID: 19853906 [PubMed - in process]Related articles

    4.

    Prevalence of loss of function FTO mutations in lean and obese individuals.

    Meyre D, Proulx K, Kawagoe-Takaki H, Vatin V, Gutiérrez-Aguilar R, Lyon D, Ma M, Choquet H, Horber F, Van Hul W, Van Gaal L, Balkau B, Visvikis-Siest S, Pattou F, Farooqi IS, Saudek V, O'Rahilly S, Froguel P, Sedgwick B, Yeo GS.

    Diabetes. 2009 Oct 15. [Epub ahead of print]PMID: 19833892 [PubMed - as supplied by publisher]Related articles

    5.

    The role of the leptin-melanocortin signalling pathway in the control of food intake.

    Beckers S, Zegers D, Van Gaal LF, Van Hul W.

    Crit Rev Eukaryot Gene Expr. 2009;19(4):267-87.PMID: 19817705 [PubMed - in process]Related articles

    6.

    Early Response to Sibutramine in Patients Not Meeting Current Label Criteria: Preliminary Analysis of SCOUT Lead-in Period.

    Caterson I, Coutinho W, Finer N, Van Gaal L, Maggioni A, Torp-Pedersen C, Sharma AM, Ge H, Santoro D, Shepherd G, James P; ; for The SCOUT Investigators.

    Obesity (Silver Spring). 2009 Oct 8. [Epub ahead of print]PMID: 19816415 [PubMed - as supplied by publisher]Related articles

    7.

    Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial.

    Van Gaal LF, Caterson ID, Coutinho W, Finer N, Maggioni AP, Sharma AM, Torp-Pedersen C, Ge H, Moran SA, Shepherd GM, James WP; on behalf of the SCOUT Investigators.

    Diabetes Obes Metab. 2009 Sep 16. [Epub ahead of print]PMID: 19758358 [PubMed - as supplied by publisher]Related articles

    8.

    Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects.

    Di Marzo V, Verrijken A, Hakkarainen A, Petrosino S, Mertens I, Lundbom N, Piscitelli F, Westerbacka J, Soro-Paavonen A, Matias I, Van Gaal L, Taskinen MR.

    Eur J Endocrinol. 2009 Nov;161(5):715-22. Epub 2009 Sep 10.PMID: 19745037 [PubMed - indexed for MEDLINE]Related articles

    9.

    Association study and mutation analysis of adiponectin shows association of variants in APM1 with complex obesity in women.

    Beckers S, Peeters AV, de Freitas F, Mertens IL, Verhulst SL, Haentjens D, Desager KN, Van Gaal LF, Van Hul W.

    Ann Hum Genet. 2009 Sep;73(Pt 5):492-501. Epub 2009 Jul 1.PMID: 19573164 [PubMed - in process]Related articles

    10.

    GLP-1 receptor agonists for type 2 diabetes.

    De Block CE, Van Gaal LF.

    Lancet. 2009 Jul 4;374(9683):4-6. Epub 2009 Jun 8. Review. No abstract available. PMID: 19515414 [PubMed - indexed for MEDLINE]Related articles

    11.

    Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial.

    Andersson C, Weeke P, Fosbøl EL, Brendorp B, Køber L, Coutinho W, Sharma AM, Van Gaal L, Finer N, James WP, Caterson ID, Rode RA, Torp-Pedersen C; SCOUT Executive Steering Committee; SCOUT investigators.

    Metabolism. 2009 Aug;58(8):1109-15. Epub 2009 Jun 18.PMID: 19454355 [PubMed - indexed for MEDLINE]Related articles

    12.

    Possible role for ENPP1 polymorphism in obesity but not for INSIG2 and PLIN variants.

    Peeters A, Beckers S, Verrijken A, Mertens I, Van Gaal L, Van Hul W.

    Endocrine. 2009 Aug;36(1):103-9. Epub 2009 Apr 28.PMID: 19399648 [PubMed - indexed for MEDLINE]Related articles

    13.

    Early endothelial dysfunction in young type 1 diabetics.

    Hurks R, Eisinger MJ, Goovaerts I, van Gaal L, Vrints C, Weyler J, Hendriks J, van Schil P, Lauwers P.

    Eur J Vasc Endovasc Surg. 2009 May;37(5):611-5. Epub 2009 Mar 17.PMID: 19297215 [PubMed - indexed for MEDLINE]Related articles

    14.

    The effect of weight loss on sleep-disordered breathing in obese teenagers.

    Verhulst SL, Franckx H, Van Gaal L, De Backer W, Desager K.

    Obesity (Silver Spring). 2009 Jun;17(6):1178-83. Epub 2009 Mar 5.PMID: 19265797 [PubMed - indexed for MEDLINE]Related articles

    15.

    Low fasting triglycerides: hallmark of the healthy large hip?

    Ruige JB, Van Gaal LF.

    Obesity (Silver Spring). 2009 Aug;17(8):1621-6. Epub 2009 Feb 26.PMID: 19247283 [PubMed - indexed for MEDLINE]Related articles

    16.

    Association of SIRT1 gene variation with visceral obesity.

    Peeters AV, Beckers S, Verrijken A, Mertens I, Roevens P, Peeters PJ, Van Hul W, Van Gaal LF.

    Hum Genet. 2008 Nov;124(4):431-6. Epub 2008 Sep 27.PMID: 18820948 [PubMed - indexed for MEDLINE]Related articles

    17.

    [CB1 receptor inhibition and glucose metabolism: role of rimonabant in type 2 diabetes]

    Scheen AJ, Paquot N, Van Gaal LF.

    Rev Med Suisse. 2008 Aug 27;4(168):1812-7. Review. French. PMID: 18814765 [PubMed - indexed for MEDLINE]Related articles

    18.

    Is sleep-disordered breathing an additional risk factor for the metabolic syndrome in obese children and adolescents?

    Verhulst SL, Rooman R, Van Gaal L, De Backer W, Desager K.

    Int J Obes (Lond). 2009 Jan;33(1):8-13. Epub 2008 Sep 9. Review.PMID: 18779826 [PubMed - indexed for MEDLINE]Related articles

    19.

    Sleep-disordered breathing and proteinuria in overweight and obese children and adolescents.

    Verhulst SL, Van Hoeck K, Schrauwen N, Haentjens D, Rooman R, Van Gaal L, De Backer W, Desager KN.

    Horm Res. 2008;70(4):224-9. Epub 2008 Sep 5.PMID: 18772595 [PubMed - indexed for MEDLINE]Related articles

    20.

    Glucose control and use of continuous glucose monitoring in the intensive care unit: a critical review.

    De Block C, Manuel-y-Keenoy B, Rogiers P, Jorens P, Van Gaal L.

    Curr Diabetes Rev. 2008 Aug;4(3):234-44. Review.PMID: 18690906 [PubMed - indexed for MEDLINE]Related articles

    21.

    Minimally-invasive and non-invasive continuous glucose monitoring systems: indications, advantages, limitations and clinical aspects.

    De Block C, Vertommen J, Manuel-y-Keenoy B, Van Gaal L.

    Curr Diabetes Rev. 2008 Aug;4(3):159-68. Review.PMID: 18690896 [PubMed - indexed for MEDLINE]Related articles

    22.

    Sleep-disordered breathing, obesity, and airway inflammation in children and adolescents.

    Verhulst SL, Aerts L, Jacobs S, Schrauwen N, Haentjens D, Claes R, Vaerenberg H, Van Gaal LF, De Backer WA, Desager KN.

    Chest. 2008 Dec;134(6):1169-75. Epub 2008 Aug 8.PMID: 18689597 [PubMed - indexed for MEDLINE]Related articles

    23.

    Blood pressure changes associated with sibutramine and weight management - an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT).

    Sharma AM, Caterson ID, Coutinho W, Finer N, Van Gaal L, Maggioni AP, Torp-Pedersen C, Bacher HP, Shepherd GM, James WP; SCOUT Investigators.

    Diabetes Obes Metab. 2009 Mar;11(3):239-50. Epub 2008 Jul 29.PMID: 18671798 [PubMed - indexed for MEDLINE]Related articles

    24.

    [Endocannabinoid system in the brain...and elsewhere]

    Scheen AJ, Seutin V, Van Gaal LF.

    Rev Med Liege. 2008 May-Jun;63(5-6):364-71. French. PMID: 18669206 [PubMed - indexed for MEDLINE]Related articles

    25.

    Association of the BDNF Val66Met variation with obesity in women.

    Beckers S, Peeters A, Zegers D, Mertens I, Van Gaal L, Van Hul W.

    Mol Genet Metab. 2008 Sep-Oct;95(1-2):110-2. Epub 2008 Jul 29.PMID: 18667348 [PubMed - indexed for MEDLINE]Related articles

    26.

    Sleep-disordered breathing and systemic inflammation in overweight children and adolescents.

    Verhulst SL, Schrauwen N, Haentjens D, Rooman RP, Van Gaal L, De Backer WA, Desager KN.

    Int J Pediatr Obes. 2008;3(4):234-9.PMID: 18608625 [PubMed - indexed for MEDLINE]Related articles

    27.

    [Medication of the month... Exenatide (Byetta) incretinomimetic in the treatment of type 2 diabetes after failure and as add-on therapy to oral agents]

    Scheen AJ, Van Gaal LF.

    Rev Med Liege. 2008 Mar;63(3):158-65. Review. French. PMID: 18561773 [PubMed - indexed for MEDLINE]Related articles

    28.

    Adenotonsillectomy as first-line treatment for sleep-disordered breathing in obese children.

    Verhulst SL, De Backer J, Van Gaal L, De Backer W, Desager K.

    Am J Respir Crit Care Med. 2008 Jun 15;177(12):1399. No abstract available. PMID: 18522955 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Belgian expert opinion: how to reduce the residual risk in atherogenic dyslipidaemic patients: place of fibrates.

    Ducobu J, Scheen A, Van Gaal L, Velkeniers B, Hermans M.

    Acta Cardiol. 2008 Apr;63(2):235-48. Review.PMID: 18468206 [PubMed - indexed for MEDLINE]Related articles

    30.

    Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study.

    Van Gaal LF, Scheen AJ, Rissanen AM, Rössner S, Hanotin C, Ziegler O; RIO-Europe Study Group.

    Eur Heart J. 2008 Jul;29(14):1761-71. Epub 2008 Apr 15.PMID: 18417461 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    The prevalence, anatomical correlates and treatment of sleep-disordered breathing in obese children and adolescents.

    Verhulst SL, Van Gaal L, De Backer W, Desager K.

    Sleep Med Rev. 2008 Oct;12(5):339-46. Epub 2008 Apr 11. Review.PMID: 18406637 [PubMed - indexed for MEDLINE]Related articles

    32.

    The metabolic syndrome and the liver.

    Verrijken A, Francque S, Van Gaal L.

    Acta Gastroenterol Belg. 2008 Jan-Mar;71(1):48-59.PMID: 18396752 [PubMed - indexed for MEDLINE]Related articles

    33.

    [Sitagliptine (Januvia): incretin enhancer potentiating insulin secretion for the treatment of type 2 diabetes]

    Scheen AJ, Van Gaal LF.

    Rev Med Liege. 2008 Feb;63(2):105-9. French. PMID: 18372550 [PubMed - indexed for MEDLINE]Related articles

    34.

    Exploiting the antidiabetic properties of incretins to treat type 2 diabetes mellitus: glucagon-like peptide 1 receptor agonists or insulin for patients with inadequate glycemic control?

    Van Gaal LF, Gutkin SW, Nauck MA.

    Eur J Endocrinol. 2008 Jun;158(6):773-84. Epub 2008 Mar 5. Review.PMID: 18322302 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Overweight in adolescents: differences per type of education. Does one size fit all?

    Vissers D, Devoogdt N, Gebruers N, Mertens I, Truijen S, Van Gaal L.

    J Nutr Educ Behav. 2008 Mar-Apr;40(2):65-71.PMID: 18314081 [PubMed - indexed for MEDLINE]Related articles

    36.

    [Medication of the month. Rimonabant (Acomplia): first CB1 receptor antagonist of the endocannabinoid system]

    Scheen AJ, Van Gaal LF.

    Rev Med Liege. 2008 Jan;63(1):50-5. Review. French. PMID: 18303686 [PubMed - indexed for MEDLINE]Related articles

    37.

    Efficacy and safety of the weight-loss drug rimonabant.

    Després JP, Van Gaal L, Pi-Sunyer X, Scheen A.

    Lancet. 2008 Feb 16;371(9612):555; author reply 556-7. No abstract available. PMID: 18280320 [PubMed - indexed for MEDLINE]Related articles

    38.

    Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program.

    Van Gaal L, Pi-Sunyer X, Després JP, McCarthy C, Scheen A.

    Diabetes Care. 2008 Feb;31 Suppl 2:S229-40.PMID: 18227491 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Analysis of genetic variations in the resistin gene shows no associations with obesity in women.

    Beckers S, Peeters AV, Freitas F, Mertens IL, Hendrickx JJ, Van Gaal LF, Van Hul W.

    Obesity (Silver Spring). 2008 Apr;16(4):905-7. Epub 2008 Jan 24.PMID: 18239575 [PubMed - indexed for MEDLINE]Related articles

    40.

    Current concepts in gastric motility in diabetes mellitus.

    De Block CE, De Leeuw IH, Pelckmans PA, Van Gaal LF.

    Curr Diabetes Rev. 2006 Feb;2(1):113-30. Review.PMID: 18220621 [PubMed - indexed for MEDLINE]Related articles

    41.

    Effect of rimonabant on blood pressure in overweight/obese patients with/without co-morbidities: analysis of pooled RIO study results.

    Ruilope LM, Després JP, Scheen A, Pi-Sunyer X, Mancia G, Zanchetti A, Van Gaal L.

    J Hypertens. 2008 Feb;26(2):357-67.PMID: 18192851 [PubMed - indexed for MEDLINE]Related articles

    42.

    Sleep duration and metabolic dysregulation in overweight children and adolescents.

    Verhulst SL, Schrauwen N, Haentjens D, Rooman RP, Van Gaal L, De Backer WA, Desager KN.

    Arch Dis Child. 2008 Jan;93(1):89-90. No abstract available. PMID: 18156481 [PubMed - indexed for MEDLINE]Related articles

    43.

    Variants in the FTO gene are associated with common obesity in the Belgian population.

    Peeters A, Beckers S, Verrijken A, Roevens P, Peeters P, Van Gaal L, Van Hul W.

    Mol Genet Metab. 2008 Apr;93(4):481-4. Epub 2007 Dec 4.PMID: 18055244 [PubMed - indexed for MEDLINE]Related articles

    44.

    Autoimmune gastritis in type 1 diabetes: a clinically oriented review.

    De Block CE, De Leeuw IH, Van Gaal LF.

    J Clin Endocrinol Metab. 2008 Feb;93(2):363-71. Epub 2007 Nov 20. Review.PMID: 18029461 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries.

    Balkau B, Deanfield JE, Després JP, Bassand JP, Fox KA, Smith SC Jr, Barter P, Tan CE, Van Gaal L, Wittchen HU, Massien C, Haffner SM.

    Circulation. 2007 Oct 23;116(17):1942-51.PMID: 17965405 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Metabolic syndrome in youth: a cross-sectional school-based survey.

    Vissers D, Vanroy C, De Meulenaere A, Van de Sompel A, Truijen S, Van Gaal L.

    Acta Paediatr. 2007 Dec;96(12):1809-13. Epub 2007 Oct 22.PMID: 17953732 [PubMed - indexed for MEDLINE]Related articles

    47.

    Reducing cardiometabolic risk through selective antagonism of CB1 receptors.

    Van Gaal L.

    Clin Cornerstone. 2007;8 Suppl 6:S24-9. Review.PMID: 17948364 [PubMed - indexed for MEDLINE]Related articles

    48.

    PAI-1 activity, but not fibrinogen or von Willebrand factor, is inversely related to LDL particle size in type 2 diabetes.

    Mertens I, Lemieux I, Verrijken A, Després JP, Van Gaal LF.

    Diabetes Metab Res Rev. 2008 Feb;24(2):141-7.PMID: 17922472 [PubMed - indexed for MEDLINE]Related articles

    49.

    Sleep duration and insulin resistance in obese children: when variables are sleeping too close together.

    Verhulst SL, Desager K, Van Gaal L, De Backer W.

    J Pediatr. 2007 Oct;151(4):e14; author reply e14-5. No abstract available. PMID: 17889055 [PubMed - indexed for MEDLINE]Related articles

    50.

    The safety of obesity drugs.

    Van Gaal LF, Scheen AJ, Formiguera X.

    Expert Opin Drug Saf. 2007 Sep;6(5):475-6; author reply 477-8. No abstract available. PMID: 17877434 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...